Literature DB >> 25487032

Design and identification of a high efficient formic acid cleavage site for separation of fusion protein.

Huaguang Zhang1, Mei Li, Shuangfeng Shi, Chao Yin, Shirong Jia, Zhixing Wang, Yuhui Liu.   

Abstract

The release of target protein with high efficiency and low cost from expressed fusion protein is a key requirement for commercial production of target proteins. To establish such a cleavage system, we have designed four formic acid (FA) cleavage sites C1 (DPDPDP), C2 (DPPDPP), C3 (DDDDPI) and C4 (IVDPNP), which was placed in between the E and G fusion protein. Four expression vectors were individually constructed and expressed in Escherichia coli. Purified proteins were reacted with a series of FA concentrations or under different temperatures followed by SDS-PAGE gel electrophoresis to verify the degree of cleavage efficiency. Results showed that the C2 was the most efficient site compared with the other three. After optimization of cleavage conditions for E-C2-G, the cleavage efficiently could reach as high as 87.3% within 2.5 h in 37% FA at 45 °C. Comparing with previous reports, a significant reduction (26%) of FA concentration at a lower temperature in a short duration of reaction (18 times less) was achieved. We believe the cleavage site of DPPDPP identified in this study can be used in the large-scale production of valuable fusion proteins to save the cost, time and energy.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25487032     DOI: 10.1007/s10930-014-9592-8

Source DB:  PubMed          Journal:  Protein J        ISSN: 1572-3887            Impact factor:   2.371


  20 in total

1.  The low pH in trans-Golgi triggers autocatalytic cleavage of pre-alpha -inhibitor heavy chain precursor.

Authors:  M Thuveson; E Fries
Journal:  J Biol Chem       Date:  2000-10-06       Impact factor: 5.157

2.  Chemical cleavage of fusion proteins for high-level production of transmembrane peptides and protein domains containing conserved methionines.

Authors:  Jian Hu; Huajun Qin; Mukesh Sharma; Timothy A Cross; Fei Philip Gao
Journal:  Biochim Biophys Acta       Date:  2008-01-11

3.  Cleavage at aspartyl-prolyl bonds.

Authors: 
Journal:  Methods Enzymol       Date:  1977       Impact factor: 1.600

4.  Construction and activity of a novel GHRH analog, Pro-Pro-hGHRH(1-44)-Gly-Gly-Cys.

Authors:  Song-shan Tang; Juan-hui Zhang; Ming-hua Du; Jie Wu; Jing-jing Liu
Journal:  Acta Pharmacol Sin       Date:  2004-11       Impact factor: 6.150

5.  Production and enhanced biological activity of a novel GHRH analog, hGHRH with an N-terminal Pro-Pro extension.

Authors:  Song-shan Tang; Zheng-lan Chen; Jing-jing Liu
Journal:  Protein Expr Purif       Date:  2004-04       Impact factor: 1.650

6.  Optimization of the hydroxylamine cleavage of an expressed fusion protein to produce recombinant human insulin-like growth factor (IGF)-I.

Authors:  S J Milner; S M Thomas; F J Ballard; G L Francis
Journal:  Biotechnol Bioeng       Date:  1996-05-05       Impact factor: 4.530

7.  Expression in Escherichia coli of a chemically synthesized gene for the hormone somatostatin.

Authors:  K Itakura; T Hirose; R Crea; A D Riggs; H L Heyneker; F Bolivar; H W Boyer
Journal:  Science       Date:  1977-12-09       Impact factor: 47.728

8.  Conformational study of cyclo[D-Trp-D-Asp-Pro-D-Val-Leu], an endothelin-A receptor-selective antagonist.

Authors:  R A Atkinson; J T Pelton
Journal:  FEBS Lett       Date:  1992-01-13       Impact factor: 4.124

9.  Recombinant DNA procedures for producing small antimicrobial cationic peptides in bacteria.

Authors:  K L Piers; M H Brown; R E Hancock
Journal:  Gene       Date:  1993-11-30       Impact factor: 3.688

10.  A novel purification method for histidine-tagged proteins containing a thrombin cleavage site.

Authors:  M H Hefti; C J Van Vugt-Van der Toorn; R Dixon; J Vervoort
Journal:  Anal Biochem       Date:  2001-08-15       Impact factor: 3.365

View more
  1 in total

1.  Reductive site-selective atypical C,Z-type/N2-C2 cleavage allows C-terminal protein amidation.

Authors:  Tim A Mollner; Andrew M Giltrap; Yibo Zeng; Yana Demyanenko; Charles Buchanan; Daniel Oehlrich; Andrew J Baldwin; Daniel C Anthony; Shabaz Mohammed; Benjamin G Davis
Journal:  Sci Adv       Date:  2022-04-08       Impact factor: 14.136

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.